Addition Therapeutics
PrivateLast Round
Series A
Dec 17, 2025
Total Funding Raised
$100M
Company Overview
Addition Therapeutics is a biotechnology company developing a new class of genomic medicines using its all-RNA, non-viral, LNP-based PRINT (Precise RNA-Mediated Insertion of Transgenes) platform to create one-time therapies for chronic and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Addition Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Addition Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 17, 2025 |
Addition Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Series A |
| Gates Family Foundation | Series A |
| Osage University Partners | Series A |
| Gates Foundation | Series A |
| Abingworth | Series A |
| Pivotal bioVenture Partners | Series A |
| Pivotal Life Sciences | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Developing a gene therapy for permanent GLP-1 production in liver cells.
- Dec 17, 2025
Developing new gene therapies for rare and chronic diseases.
Addition Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Addition Therapeutics's valuation, stock price, and market status.
